1. Home
  2. SILO vs ADXN Comparison

SILO vs ADXN Comparison

Compare SILO & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SILO
  • ADXN
  • Stock Information
  • Founded
  • SILO 2010
  • ADXN 2002
  • Country
  • SILO United States
  • ADXN Switzerland
  • Employees
  • SILO N/A
  • ADXN N/A
  • Industry
  • SILO Apparel
  • ADXN Biotechnology: Pharmaceutical Preparations
  • Sector
  • SILO Consumer Discretionary
  • ADXN Health Care
  • Exchange
  • SILO Nasdaq
  • ADXN Nasdaq
  • Market Cap
  • SILO 8.8M
  • ADXN 8.0M
  • IPO Year
  • SILO N/A
  • ADXN N/A
  • Fundamental
  • Price
  • SILO $1.42
  • ADXN $7.49
  • Analyst Decision
  • SILO
  • ADXN Strong Buy
  • Analyst Count
  • SILO 0
  • ADXN 1
  • Target Price
  • SILO N/A
  • ADXN $30.00
  • AVG Volume (30 Days)
  • SILO 349.9K
  • ADXN 17.9K
  • Earning Date
  • SILO 02-18-2025
  • ADXN 03-24-2025
  • Dividend Yield
  • SILO N/A
  • ADXN N/A
  • EPS Growth
  • SILO N/A
  • ADXN N/A
  • EPS
  • SILO N/A
  • ADXN 0.06
  • Revenue
  • SILO $72,102.00
  • ADXN $701,260.00
  • Revenue This Year
  • SILO $1.86
  • ADXN N/A
  • Revenue Next Year
  • SILO N/A
  • ADXN N/A
  • P/E Ratio
  • SILO N/A
  • ADXN $0.92
  • Revenue Growth
  • SILO N/A
  • ADXN N/A
  • 52 Week Low
  • SILO $0.77
  • ADXN $6.73
  • 52 Week High
  • SILO $4.50
  • ADXN $27.90
  • Technical
  • Relative Strength Index (RSI)
  • SILO 48.83
  • ADXN 42.98
  • Support Level
  • SILO $1.42
  • ADXN $6.73
  • Resistance Level
  • SILO $1.57
  • ADXN $7.90
  • Average True Range (ATR)
  • SILO 0.16
  • ADXN 0.41
  • MACD
  • SILO -0.06
  • ADXN -0.07
  • Stochastic Oscillator
  • SILO 25.23
  • ADXN 18.29

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

About ADXN Addex Therapeutics Ltd

Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.

Share on Social Networks: